Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-19
SponsorUniversity of British Columbia

About this trial

The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care.

Participants will be randomized to receive Usual Care or the AHEAD Program, which provides tailored support to emerging adults to build autonomy and competence to facilitate independent diabetes management. Researchers will compare changes in glycemia and participant-reported outcomes between groups.

Eligibility criteria

Qualifiers

16-19 years of age

Have had type 1 diabetes ≥ 12 months

Had a recent HbA1c ≥7.0%

Currently receive outpatient diabetes care at a Seattle Children's Hospital Diabetes Clinic located in Bellevue, Everett, Federal Way, or Seattle

Disqualifiers

Have had a pilot program AHEAD clinic visit

Most recent Usual Care diabetes visit was with a current AHEAD provider

Trial design

Treatments tested in this trial

  • AHEAD Program

Treatment groups

306 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of British Columbia

Lead sponsor

Breakthrough T1D

Collaborator

Seattle Children's Hospital

Collaborator

University of Washington

Collaborator

Kaiser Permanente

Collaborator